Table 3 Mortality (Cox regression)
From: Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
Variables | B | S.E. | Wald (df = 1) | p-value | OR |
|---|---|---|---|---|---|
Gender (male) | .053 | .043 | 1.507 | .220 | 1.054 |
Age start (Year) | .013 | .004 | 12.927 | .000 | 1.013 |
Socioeconomic (low) | .083 | .057 | 2.093 | .148 | 1.086 |
Smoking | .162 | .061 | 7.135 | .008 | 1.176 |
Alcohol | .323 | .240 | 1.809 | .179 | 1.381 |
Hypertension | .032 | .056 | .322 | .570 | 1.032 |
Diabetes | .015 | .046 | .106 | .745 | 1.015 |
Obesity | .071 | .054 | 1.724 | .189 | 1.073 |
Congestive heart failure | .172 | .055 | 9.779 | .002 | 1.187 |
Liver cancer | .775 | .516 | 2.255 | .133 | 2.170 |
Ischemic heart disease | .000 | .046 | .000 | .993 | 1.000 |
Cerebrovascular accident | .153 | .051 | 9.065 | .003 | 1.166 |
Bevacizumab use | .527 | .043 | 153.744 | .000 | 1.694 |